Widening use of dexamethasone implant for the treatment of macular edema
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolyme...
Saved in:
Volume: | 11 |
---|---|
Main Author: |
Bonfiglio, Vincenza
Reibaldi, Michele Fallico, Matteo Russo, Andrea Pizzo, Alessandra Fichera, Stefano Rapisarda, Carlo Macchi, Iacopo Avitabile, Teresio Longo, Antonio |
Format: | Journal Article |
Language: | English |
Zielgruppe: |
Academic |
Place of publication: |
ALBANY DOVE MEDICAL PRESS LTD 01.01.2017 Dove Medical Press Limited Dove Medical Press |
published in: | Drug design, development and therapy Vol. 11; pp. 2359 - 2372 |
Data of publication: | 2017-01-01 |
ISSN: |
1177-8881 1177-8881 |
EISSN: |
1177-8881 |
Discipline: | Pharmacy, Therapeutics, & Pharmacology |
Subjects: | |
Online Access: |
Fulltext |
Database: | Web of Science - Science Citation Index Expanded - 2017 Web of Knowledge Science Citation Index Expanded Web of Science MEDLINE (Ovid) PubMed MEDLINE MEDLINE MEDLINE Medline CrossRef MEDLINE - Academic Directory of Open Access Journals Database information Databases - DBIS |